Caron experts weigh in on how even the treatment industry is at risk amidst the nation’s opioid crisis

Caron’s CEO Doug Tieman and Executive Vice President and Chief Clinical Officer Dave Rotenberg discuss the impact of the opioid crisis on treatment industry employees.

See story in Philadelphia Inquirer